Least Burdensome Task Force Gathers Testimony For FDAMA Hearing

The "least burdensome" industry task force plans to respond to FDA's recently released draft guidance by formulating testimony for an upcoming congressional hearing on the FDA Modernization Act, and submitting comments to the agency, industry sources report.